8yt9
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Human PPAR alpha ligand binding domain in complex with a 1H-pyrazolo[3,4-b]pyridine-derived compound== | |
- | + | <StructureSection load='8yt9' size='340' side='right'caption='[[8yt9]], [[Resolution|resolution]] 1.59Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[8yt9]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8YT9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8YT9 FirstGlance]. <br> | |
- | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.59Å</td></tr> | |
- | [[Category: | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=A1LZY:1-(4-fluorophenyl)-6-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-3-pentan-3-yl-pyrazolo[3,4-b]pyridine-4-carboxylic+acid'>A1LZY</scene></td></tr> |
- | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8yt9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8yt9 OCA], [https://pdbe.org/8yt9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8yt9 RCSB], [https://www.ebi.ac.uk/pdbsum/8yt9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8yt9 ProSAT]</span></td></tr> |
- | [[Category: | + | </table> |
- | [[Category: Fukuda | + | == Function == |
- | [[Category: | + | [https://www.uniprot.org/uniprot/PPARA_HUMAN PPARA_HUMAN] Ligand-activated transcription factor. Key regulator of lipid metabolism. Activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety (By similarity). Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the ACOX1 and P450 genes. Transactivation activity requires heterodimerization with RXRA and is antagonized by NR2C2.<ref>PMID:7684926</ref> <ref>PMID:7629123</ref> <ref>PMID:9556573</ref> <ref>PMID:10195690</ref> |
- | [[Category: | + | == References == |
- | [[Category: | + | <references/> |
- | [[Category: | + | __TOC__ |
- | [[Category: | + | </StructureSection> |
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: Nakagawa | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Akai S]] |
- | [[Category: | + | [[Category: Doi T]] |
- | [[Category: | + | [[Category: Fukuda S]] |
- | [[Category: | + | [[Category: Ishimoto K]] |
- | [[Category: | + | [[Category: Kawahara K]] |
- | [[Category: | + | [[Category: Lin B]] |
+ | [[Category: Meguro K]] | ||
+ | [[Category: Miyachi H]] | ||
+ | [[Category: Morie T]] | ||
+ | [[Category: Nakagawa S]] | ||
+ | [[Category: Nunomura K]] | ||
+ | [[Category: Oki H]] | ||
+ | [[Category: Tachibana K]] | ||
+ | [[Category: Tsujikawa K]] | ||
+ | [[Category: Yoshida T]] | ||
+ | [[Category: Yuzuriha T]] |
Current revision
Human PPAR alpha ligand binding domain in complex with a 1H-pyrazolo[3,4-b]pyridine-derived compound
|
Categories: Homo sapiens | Large Structures | Akai S | Doi T | Fukuda S | Ishimoto K | Kawahara K | Lin B | Meguro K | Miyachi H | Morie T | Nakagawa S | Nunomura K | Oki H | Tachibana K | Tsujikawa K | Yoshida T | Yuzuriha T